Pathogen Reduction Device Shows Efficacy Against Virus Causing COVID-19 in Plasma and Platelets

摘要

Data from a new study suggests that a medical device that uses vitamin B2 and ultraviolet light for treating human blood products is effective against the virus that causes COVID-19.The study results,generated by Terumo BCT in collaboration with top researchers from Colorado State University,have been accepted for publication by Vox Sanguinis,a peer-reviewed medical journal covering haematology.Blood is considered vital medicine,and it is the backbone of the healthcare system.While there is no evidence that blood transfusions transmit COVID-19,some blood centres are using Mirasol to treat platelets and plasma as an additional layer of safety.